Latest Share Chat

REMOVE ADS

Celadon Pharmaceuticals Share News (CEL)

Celadon Pharmaceuticals Information

This share is currently suspended. It was suspended at a price of 13.40

There is currently no data for CEL

REMOVE ADS

Celadon Pharmaceuticals News

AIM WINNERS & LOSERS: Gelion charges higher on battery test boost

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.

IN BRIEF: Celadon receives GBP492,000 in loan, tax credit payments

Celadon Pharmaceuticals PLC - London-based pharmaceutical company, focused on cannabis-based medicines - Says it has received the final GBP103,000 fro...

Celadon still seeking finance as it draws down most of facility

(Sharecast News) - Celadon Pharmaceuticals reported on Friday that it has received £0.897m of a £1m drawdown request from its committed cred...

LONDON MARKET MIDDAY: Stocks up but Pearson, Dunelm fail to impress

(Alliance News) - Stock prices in London were higher at midday on Thursday, shrugging off the Office for National Statistics' report of "sluggish" GDP...

AIM WINNERS & LOSERS: Deltex to cancel "onerous" AIM listing

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.

LONDON MARKET OPEN: FTSE 100 higher but Taylor Wimpey leads laggers

(Alliance News) - Stock prices in London opened higher on Thursday, despite early data showing that UK GDP growth undershot expectations and that the ...

IN BRIEF: Celadon receives payment, has working capital to March

Celadon Pharmaceuticals PLC - London-based pharmaceutical company, focused on cannabis-based medicines - Says the provider of its committed credit fac...

TRADING UPDATES: SDX plots AIM exit; Celadon receives funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: